
Languages Spoken: English
Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.
Clinical Locations
Clinic 2B, GU
801-587-4644
Fax: (801) 585-0155
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Professor |
Academic Divisions | Oncology |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5

Care provider's explanation of condition/problem
4.8/ 5

Care provider's effort to include me in decisions
4.8/ 5

Wait time at clinic
4.6/ 5

Care provider's concern for questions & worries
4.8/ 5

Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
October 02, 2022
HUNTSMAN CANCER CENTER
Facility is top notch, I wouldn't go anywhere else!!
UofU Patient
September 26, 2022
HUNTSMAN CANCER CENTER
Dr. Kohli and his staff are wonderful! I know they are concerned about me and are doing their very best in caring for me. They're awesome!!
UofU Patient
September 17, 2022
HUNTSMAN CANCER CENTER
Amazing
UofU Patient
September 04, 2022
HUNTSMAN CANCER CENTER
Dr. Kohli is the best!
UofU Patient
July 23, 2022
HUNTSMAN CANCER CENTER
I am very pleased to be in remission and grateful to Dr Kohli's office for their great service and guidance.
UofU Patient
July 17, 2022
HUNTSMAN CANCER CENTER
Dr. Kohli is wonderful
UofU Patient
May 28, 2022
HUNTSMAN CANCER CENTER
We love Dr. Kohli !!
UofU Patient
May 03, 2022
HUNTSMAN CANCER CENTER
Excellent, no problem and very good about the communication of my condition or situation I am in. I do highly recommend my provider to others.
UofU Patient
February 14, 2022
HUNTSMAN CANCER CENTER
Dr. Kohli is fantastic!! So is his team!
UofU Patient
December 14, 2021
HUNTSMAN CANCER CENTER
Dr Kohli and his Nurses were very well knowledged and welcomed all of my questions
UofU Patient
December 04, 2021
HUNTSMAN CANCER CENTER
Very happy with the staff and doctor.
UofU Patient
December 04, 2021
HUNTSMAN CANCER CENTER
They were all very good and professional
UofU Patient
November 23, 2021
HUNTSMAN CANCER CENTER
My provider gets 100% HE was great my Doctor
UofU Patient
November 08, 2021
HUNTSMAN CANCER CENTER
Dr. Kohli is the best!!
UofU Patient
October 11, 2021
HUNTSMAN CANCER CENTER
Just not ready for this type of medication
UofU Patient
October 09, 2021
HUNTSMAN CANCER CENTER
Dr Kohl's and his regular staff are outstanding. Smarty pants was horrid! Never seen or interacted with him before and never want to see him again.
UofU Patient
September 13, 2021
HUNTSMAN CANCER CENTER
Dr. Kohli is the best!
UofU Patient
August 01, 2021
HUNTSMAN CANCER CENTER
Love Dr.Kholi and all his assistants.
UofU Patient
July 19, 2021
HUNTSMAN CANCER CENTER
Very through
UofU Patient
July 17, 2021
HUNTSMAN CANCER CENTER
We really like Dr. Kohli, he's wonderful and we feel very confident in him.
UofU Patient
June 22, 2021
HUNTSMAN CANCER CENTER
Great Experience. Dr Kohli is Outstanding doctor.
UofU Patient
March 27, 2021
HUNTSMAN CANCER CENTER
my experience was excellent
UofU Patient
March 06, 2021
HUNTSMAN CANCER CENTER
I. as mvery pleased
Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.
Academic Locations
Primary Children’s and Families’ Cancer Research Center
801-585-0255
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Professor |
Academic Divisions | Oncology |
Research Interests
- Genomic and Liquid Biopsy Research
- Genitourinary Cancers
Education History
Certification | Harvard Medical School Global Clinical Scholars Research Training Program; Clinical Trials Concentration Certificate, 2015 |
Fellowship | University of Arkansas for Medical Sciences Hematology/Oncology Fellow, 1999 |
Residency | Cook County Hospital Internal Medicine Resident, 1996 |
Professional Medical | Maulana Azad Medical College, University of Delhi Medicine/Surgery M.B.B.S., 1990 |
Selected Publications - Journal Articles
Journal Article
- Yoo M, Nelson RE, Cutshall Z, Dougherty M, Kohli M (2023). Cost-Effectiveness Analysis of Six Immunotherapy-Based Regimens and Sunitinib in Metastatic Renal Cell Carcinoma: A Public Payer Perspective. JCO Oncol Pract, OP2200447.
- Sicotte H, Kalari KR, Qin S, Dehm SM, Bhargava V, Gormley M, Tan W, Sinnwell JP, Hillman DW, Li Y, Vedell PT, Carlson RE, Bryce AH, Jimenez RE, Weinshilboum RM, Kohli M, Wang L (2022). Molecular profile changes in castrate resistant prostate cancer patients pre and post-abiraterone/prednisone treatment. Mol Cancer Res.
- Zimmerman R, Bilen MA, Heath EI, Nandagopal L, Swami U, Kessel A, Jaeger E, Wesolowski S, Hernanadez EJ, Chipman J, Mack A, Ravindranathan D, Maughan BL, Nussenzveig R, Yandell M, Kohli M, Lilly MB, Sartor AO, Agarwal N, Barata PC (2022). Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race. Oncologist, 27(10), e815-e818.